The Treatment of Adult ADHD: Complexity at Hand
作者： Stefano Pallanti , Luana Salerno
DOI: 10.1007/978-3-030-39051-8_19
关键词: Emotional dysregulation 、 Neuropsychology 、 Comorbidity 、 Impulsivity 、 Etiology 、 Cognition 、 Clinical psychology 、 Genetic heterogeneity 、 Medicine 、 Atomoxetine
摘要: ADHD is a highly heterogeneous disorder, characterized by multifactorial etiological risk factors, different severity of symptoms, and impact the neuropsychological impairments on functioning individual. Moreover, comorbidity with other psychiatric conditions frequent, so all these aspects can lead to variety cognitive behavioral profiles. The phenotypic heterogeneity in also coupled response treatment, order provide specific targeted interventions, it should be mandatory address dimensions (i.e., inattention, impulsivity, hyperactivity, emotional dysregulation) that appeared most affected when patient asked for help.
springer.com
sci-hub.st 参考文章(268)
Jan Dirk Blom, J. J.S. Kooij, [ADD psychosis: treatment with antipsychotics and methylphenidate?]. Tijdschrift voor psychiatrie. ,vol. 54, pp. 89- 93 ,(2012)
George Hadjipavlou, Serge Beaulieu, Margaret Weiss, Ayal Schaffer, Roger S McIntyre, Raymond W Lam, David J Bond, Anxiety Treatments (Canmat) Task Force, The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. ,vol. 24, pp. 23- 37 ,(2012)
Suntanu Dalal, Ronald Melzack, Potentiation of Opioid Analgesia by Psychostimulant Drugs: A Review Journal of Pain and Symptom Management. ,vol. 16, pp. 245- 253 ,(1998) , 10.1016/S0885-3924(98)00084-0
John S. Markowitz, Hao Jie Zhu, C. L. DeVane, S. Ramamoorthy, The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor. Die Pharmazie. ,vol. 64, pp. 123- 125 ,(2009) , 10.1691/PH.2009.8691
Scott H Kollins, Robert Lasser, Michael E Thase, Sharon Youcha, Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder. Innovations in clinical neuroscience. ,vol. 8, pp. 28- 32 ,(2011)
Akira Kugaya, Tatsuo Akechi, Ichiro Mikami, Tomohito Nakano, Yosuke Uchitomi, Toru Okuyama, Hitoshi Okamura, Algorithm for the treatment of major depression in patients with advanced cancer. Psychiatry and Clinical Neurosciences. ,vol. 53, ,(1999)
Kay, Opler La, Bellak L, Attention deficit disorder psychosis as a diagnostic category. Psychiatric developments. ,vol. 5, pp. 239- ,(1987)
Teruhiko Higuchi, Akihiko Oshima, Treatment guidelines for geriatric mood disorders. Psychiatry and Clinical Neurosciences. ,vol. 53, ,(1999)
Kayhan Bahali, None, Atomoxetine-induced mania-like symptoms in an adolescent patient. Actas Espanolas De Psiquiatria. ,vol. 41, pp. 137- 138 ,(2013)
Steven D Passik, Kenneth L Kirsh, Dale Theobald, Kathleen Donaghy, Elizabeth Holtsclaw, Sarah Edgerton, William Dugan, Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project. Journal of Pain and Symptom Management. ,vol. 24, pp. 318- 327 ,(2002) , 10.1016/S0885-3924(02)00493-1